Cedars-Sinai Cancer
.jpg?fit=crop&auto=format)
Cedars-Sinai Cancer in Los Angeles serves one of the most diverse regions globally. Ranked No. 7 for cancer by U.S. News & World Report 2020-2021, the center’s clinicians are committed to providing compassionate, state-of-the-art care, while its scientists are carrying out the latest translational research and groundbreaking advances. The cancer enterprise includes the Samuel Oschin Comprehensive Cancer Institute, The Angeles Clinic and Research Institute, Tower Hematology Oncology Medical Group, Torrance Memorial Hunt Cancer Center and Cedars-Sinai Tarzana.
Latest from Cedars-Sinai Cancer
Pancreatic Cancer Cases Climbing, Especially in Younger Women
November 06, 2021
Article
Between 2000 and 2018, the number of pancreatic cancer cases rose, particularly among women between the ages of 15 to 35 years.
Overcoming Cancer Screening Discrepancies in the Latinx/Hispanic Communities
August 25, 2021
Article
While disparities exist in screening accessibility among the Hispanic/Latinx communities, the implementation of interventions have shown promising results in increased clinical trial participation.
KRAS Inhibitors Meet New Turning Point in Non-Small Cell Lung Cancer
August 17, 2021
Article
The continued development of KRAS G12C inhibitors for the treatment of non-small cell lung cancer shows that researchers are making breakthroughs in the treatment landscape.